Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-effectiveness of novel antiandrogens (AAs) for treatment of nonmetastatic castrate-resistant prostate cancer (nmCRPC).
PaperCitations, authors & open-access status
Cost-effectiveness of novel antiandrogens (AAs) for treatment of nonmetastatic castrate-resistant prostate cancer (nmCRPC). is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 7 citations, 2020 year and closed oa status.
7
Citations
2020
Year
closed
OA Status